v3 Template
H
HCW Biologics Inc.
Biotechnology
Miramar, Florida, USA
Founded
--
Employees
--
Total Funding
$53.2M
Funding Rounds
8
Last Funding
2026-07-29
About HCW Biologics Inc.
HCW Biologics is focused on developing transformative immunotherapies to treat diseases linked to aging and chronic inflammation, addressing the health challenges associated with inflammaging.
Products & Services
Immunotherapies:Innovative treatments targeting diseases related to aging and chronic inflammation.
Pipeline:A range of therapeutic candidates under development for chronic inflammation and related conditions.
Specialties
Immunotherapy
Inflammaging
Chronic Inflammation
Aging-related Diseases
Fusion immunotherapeutics
Autoimmune diseases
Cancer immunotherapy
Aging-related diseases
Chronic inflammation
Senescence-associated dysplasia
Chronic inflammation treatments
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Private Placement T: - FT: Private Placement |
A: 1600000 MR: - FA: $1.6M FAN: 1600000 |
D: 2026-07-29 FD: 2026-07-29 |
1 investors |
| 2 |
RT: Private Placement T: - FT: Private Placement |
A: 4000000 MR: - FA: $4.0 million FAN: 4000000 |
D: 2026-05-22 FD: 2026-05-22 |
- |
| 3 |
RT: Private Placement T: - FT: Private Placement |
A: 4000000 MR: - FA: Approximately $4.0 Million FAN: 4000000 |
D: 2026-05-21 FD: 2026-05-21 |
1 investors |
| 4 |
RT: Follow-On Offering T: - FT: Follow-On Offering |
A: 1500000 MR: - FA: $1.5 million FAN: 1500000 |
D: 2026-02-17 FD: 2026-02-17 |
1 investors |
| 5 |
RT: Warrant Inducement T: - FT: Warrant Inducement |
A: 4000000 MR: - FA: 4.0 million FAN: 4000000 |
D: 2025-11-19 FD: 2025-11-19 |
1 investors |
| 6 |
RT: Follow-on Offering T: - FT: Follow-on Offering |
A: 5000000 MR: - FA: $5.0 million FAN: 5000000 |
D: 2025-05-13 FD: 2025-05-13 |
1 investors |
| 7 |
RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement |
A: 6900000 MR: - FA: $6.9 million FAN: 6900000 |
D: 2024-11-18 FD: 2024-11-18 |
1 investors |
| 8 |
RT: Debt T: - FT: Debt |
A: 26250000 MR: - FA: $26.25 million FAN: 26250000 |
D: 2023-04-27 FD: 2023-04-27 |
- |
Private Placement
Latest
2026-07-29
$1.6M
1 investor (Pro only)
Private Placement
2026-05-22
$4.0M
Private Placement
2026-05-21
$4.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
HCW Biologics Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- hcwbiologics.com
- Industries
- Biotechnology
- Locations
-
Miramar, Florida, USA
MIRAMAR, Fla.
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro